In pancreatic cancer, the ratio of Tregs to CD4+ T (%Treg) has demonstrated a significant association with shorter survival, while tumor-infiltrating CD4+ Thigh/CD8+ Thigh/%Treglow independently predicted longer overall survival [26]. The gene discussed is CD4; the disease is pancreatic neoplasm.